466 related articles for article (PubMed ID: 25510418)
1. Gene therapy for neurologic manifestations of mucopolysaccharidoses.
Wolf DA; Banerjee S; Hackett PB; Whitley CB; McIvor RS; Low WC
Expert Opin Drug Deliv; 2015 Feb; 12(2):283-96. PubMed ID: 25510418
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
Lau AA; Hemsley KM
J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
[TBL] [Abstract][Full Text] [Related]
3. Treatment of brain disease in the mucopolysaccharidoses.
Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art.
de Castro MJ; Del Toro M; Giugliani R; Couce ML
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502108
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery strategies for the treatment of mucopolysaccharidoses.
Baldo G; Giugliani R; Matte U
Expert Opin Drug Deliv; 2014 Mar; 11(3):449-59. PubMed ID: 24450877
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology applied to treatment of mucopolysaccharidoses.
Schuh RS; Baldo G; Teixeira HF
Expert Opin Drug Deliv; 2016 Dec; 13(12):1709-1718. PubMed ID: 27322551
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for the treatment of mucopolysaccharidoses.
Giugliani R; Federhen A; Vairo F; Vanzella C; Pasqualim G; da Silva LM; Giugliani L; de Boer AP; de Souza CF; Matte U; Baldo G
Expert Opin Emerg Drugs; 2016; 21(1):9-26. PubMed ID: 26751109
[TBL] [Abstract][Full Text] [Related]
8. Phase I and II clinical trials for the mucopolysaccharidoses.
Poswar F; Baldo G; Giugliani R
Expert Opin Investig Drugs; 2017 Dec; 26(12):1331-1340. PubMed ID: 29065735
[TBL] [Abstract][Full Text] [Related]
9. Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses.
Sato Y; Okuyama T
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936354
[TBL] [Abstract][Full Text] [Related]
10. Current and potential therapeutic strategies for mucopolysaccharidoses.
Noh H; Lee JI
J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
[TBL] [Abstract][Full Text] [Related]
11. Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II Mice.
Hinderer C; Katz N; Louboutin JP; Bell P; Yu H; Nayal M; Kozarsky K; O'Brien WT; Goode T; Wilson JM
Hum Gene Ther; 2016 Nov; 27(11):906-915. PubMed ID: 27510804
[TBL] [Abstract][Full Text] [Related]
12. New treatments for the mucopolysaccharidoses: from pathophysiology to therapy.
Fecarotta S; Gasperini S; Parenti G
Ital J Pediatr; 2018 Nov; 44(Suppl 2):124. PubMed ID: 30442204
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for mucopolysaccharidosis.
Ponder KP; Haskins ME
Expert Opin Biol Ther; 2007 Sep; 7(9):1333-45. PubMed ID: 17727324
[TBL] [Abstract][Full Text] [Related]
14. Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.
Pan D
Curr Pharm Biotechnol; 2011 Jun; 12(6):884-96. PubMed ID: 21235445
[TBL] [Abstract][Full Text] [Related]
15. [Mucopolysaccharidosis: clinical features, diagnosis and management].
Suarez-Guerrero JL; Gómez Higuera PJ; Arias Flórez JS; Contreras-García GA
Rev Chil Pediatr; 2016; 87(4):295-304. PubMed ID: 26613630
[TBL] [Abstract][Full Text] [Related]
16.
Marcó S; Haurigot V; Bosch F
Hum Gene Ther; 2019 Oct; 30(10):1211-1221. PubMed ID: 31482754
[TBL] [Abstract][Full Text] [Related]
17. Brain Targeting in MPS-IIIA.
Sorrentino NC; Fraldi A
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():630-8. PubMed ID: 27491210
[TBL] [Abstract][Full Text] [Related]
18. Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice.
Fu H; Kang L; Jennings JS; Moy SS; Perez A; Dirosario J; McCarty DM; Muenzer J
Gene Ther; 2007 Jul; 14(14):1065-77. PubMed ID: 17460717
[TBL] [Abstract][Full Text] [Related]
19. Gene therapies for mucopolysaccharidoses.
Rossi A; Brunetti-Pierri N
J Inherit Metab Dis; 2024 Jan; 47(1):135-144. PubMed ID: 37204267
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for Mucopolysaccharidoses.
Sawamoto K; Chen HH; Alméciga-Díaz CJ; Mason RW; Tomatsu S
Mol Genet Metab; 2018 Feb; 123(2):59-68. PubMed ID: 29295764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
